Mumbai: Drugmaker Biocon has set the price band for an
initial public offering (IPO) of its clinical research services arm,
Syngene International Ltd, at Rs 240 to Rs 250 a share, it said on
Thursday.
Syngene's IPO shall open for subscription on July 27 and close on July 29, Biocon said in a filing to exchanges.
Biocon said in April that it planned to sell 22 million shares and provide an over-allotment option.
Syngene's IPO shall open for subscription on July 27 and close on July 29, Biocon said in a filing to exchanges.
Biocon said in April that it planned to sell 22 million shares and provide an over-allotment option.
No comments:
Post a Comment